Morgan Stanley analyst Andrew Scott upgraded James Hardie (JHX) to Overweight from Equal Weight with a A$55 price target. While the firm says it struggles to justify the premium paid for Azek (AZEK), the 21% month-to-date share price decline makes James Hardie shares “cheap even allowing for EPS dilution,” the analyst tells investors. Though the firm expects “volatile near-term performance,” it argues that on a medium-term basis “value cannot be ignored.”
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue